Ghent University
Ghent, 9000, Belgium
NCT Number: NCT03531580
In the Ghent University, an upgrade of the MRI-scanner used for research from Siemens Trio Tim to Siemens Prisma Fit is planned in the near future. As a change of MRI hard- and software might influence brain images, it is necessary to evaluate the images before and after the upgrade.
Looking for future studies?
Notify Me20 year and older
All sexes
Interventional
Not applicable
Ghent, 9000, Belgium
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Brain imaging using magnetic resonance imaging, using several MRI sequences: structural imaging (grey matter, using T1-imaging), cerebral perfusion using arterial spin labeling), functional and effective connectivity (using resting-state functional MRI), white matter tracts (using diffusion imaging), white matter lesions (using Fluid-attenuated inversion recovery MRI (FLAIR)) and microbleeds (using Susceptibility weighted imaging (SWI))
Time frame: 7 months, 4 scan sessions of max 1 hour
Time frame: 7 months, 4 scan sessions of max 1 hour
Time frame: 7 months, 4 scan sessions of max 1 hour
Time frame: 7 months, 4 scan sessions of max 1 hour
Time frame: 7 months, 4 scan sessions of max 1 hour
Time frame: 7 months, 4 scan sessions of max 1 hour
Time frame: 7 months, 4 scan sessions of max 1 hour
Time frame: 7 months, 4 scan sessions of max 1 hour
University Ghent
Other
Brain Images Before and After Upgrade of the MRI-scanner (Siemens Tim TRIO vs Siemens PRISMA FIT) - The TimFit Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02826733
Neuroimaging
Amiens, France
View Trial DetailsNCT01981148
Autofluorescence Imaging, Neuroimaging
Bern, Switzerland
View Trial DetailsNCT05776602
Brain Diseases, Brain Neoplasms
Stockholm, Stockholm County, Sweden
View Trial DetailsNCT02959489
Alzheimer Disease, Amyloid Beta-Peptides
Boston, Massachusetts, United States
View Trial Details